A detailed history of Candriam S.C.A. transactions in Dexcom Inc stock. As of the latest transaction made, Candriam S.C.A. holds 230,451 shares of DXCM stock, worth $18.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
230,451
Previous 115,749 99.1%
Holding current value
$18.5 Million
Previous $13.1 Million 17.69%
% of portfolio
0.09%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $7.34 Million - $13.3 Million
114,702 Added 99.1%
230,451 $15.4 Million
Q2 2024

Aug 05, 2024

SELL
$110.31 - $140.45 $6.42 Million - $8.17 Million
-58,167 Reduced 33.45%
115,749 $13.1 Million
Q1 2024

May 03, 2024

SELL
$114.22 - $140.1 $3.33 Million - $4.09 Million
-29,180 Reduced 14.37%
173,916 $24.1 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $8.78 Million - $14.4 Million
-116,247 Reduced 36.4%
203,096 $25.2 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $21.4 Million - $34.3 Million
248,729 Added 352.24%
319,343 $29.8 Million
Q2 2023

Aug 08, 2023

BUY
$112.47 - $130.98 $1.42 Million - $1.65 Million
12,586 Added 21.69%
70,614 $9.07 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $152,048 - $179,709
1,462 Added 2.58%
58,028 $6.74 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $5.91 Million - $8.53 Million
-69,503 Reduced 55.13%
56,566 $6.41 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $124,450 - $153,513
-1,630 Reduced 1.28%
126,069 $10.2 Million
Q2 2022

Aug 03, 2022

BUY
$67.99 - $132.89 $7.05 Million - $13.8 Million
103,667 Added 431.37%
127,699 $9.52 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $302,184 - $418,202
-3,212 Reduced 11.79%
24,032 $12.3 Million
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $2.85 Million - $3.57 Million
21,936 Added 413.26%
27,244 $14.6 Million
Q3 2021

Nov 09, 2021

SELL
$106.71 - $143.18 $24,650 - $33,074
-231 Reduced 4.17%
5,308 $2.9 Million
Q2 2021

Jul 20, 2021

SELL
$80.99 - $107.93 $743,974 - $991,444
-9,186 Reduced 62.38%
5,539 $2.37 Million
Q4 2020

Jan 22, 2021

SELL
$78.0 - $104.5 $57,720 - $77,330
-740 Reduced 4.78%
14,725 $5.44 Million
Q3 2020

Oct 19, 2020

SELL
$95.51 - $112.95 $573 - $677
-6 Reduced 0.04%
15,465 $6.38 Million
Q2 2020

Jul 23, 2020

BUY
$62.68 - $105.34 $546,130 - $917,827
8,713 Added 128.93%
15,471 $6.27 Million
Q4 2019

Jan 21, 2020

BUY
$36.62 - $57.29 $31,786 - $49,727
868 Added 14.74%
6,758 $1,000
Q3 2019

Oct 21, 2019

SELL
$35.53 - $43.8 $11,263 - $13,884
-317 Reduced 5.11%
5,890 $1,000
Q2 2019

Aug 01, 2019

BUY
$27.84 - $38.92 $12,360 - $17,280
444 Added 7.7%
6,207 $926,000
Q1 2019

May 02, 2019

BUY
$28.07 - $38.18 $21,754 - $29,589
775 Added 15.54%
5,763 $686,000
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $134,626 - $186,401
4,988 New
4,988 $598,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.